These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6499854)

  • 21. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term antiarrhythmic therapy with flecainide.
    Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
    Am J Cardiol; 1984 Jul; 54(1):91-6. PubMed ID: 6741844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flecainide dose-response relations in stable ventricular arrhythmias.
    Woosley RL; Siddoway LA; Duff HJ; Roden DM
    Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
    Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
    Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.
    Morganroth J; Anderson JL; Gentzkow GD
    J Am Coll Cardiol; 1986 Sep; 8(3):607-15. PubMed ID: 3745706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of flecainide in a canine 7 day old myocardial infarction model.
    Sakai T; Ogawa S; Hosokawa M; Miyazaki T; Sakurai K; Nakamura Y
    Cardiovasc Res; 1989 Mar; 23(3):177-83. PubMed ID: 2512008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
    Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effects of flecainide.
    Somani P
    Clin Pharmacol Ther; 1980 Apr; 27(4):464-70. PubMed ID: 7357804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
    Hashimoto H; Katoh H; Nakashima M
    J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of flecainide in the treatment of ventricular arrhythmia].
    Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
    Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.